Literature DB >> 30140731

Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo Activity.

Nicholas McConnell1, Zhigang Xu2, Vishnu Kumarasamy1, Daekyu Sun1, Brendan Frett3, Hong-Yu Li3.   

Abstract

Benzimidazoles and quinoxalinones are present in the core of many pharmacologically relevant compounds. Several combinatorial methods have been developed to attach ring systems to both scaffolds for derivatization at select positions. Herein, we describe the development of novel constrained heterocyclic compounds attached to the N1 position of both benzimidazole and quinoxalinone scaffolds. Utilizing robust post-Ugi cyclization methods, including the Ugi-deprotection-cyclization (UDC) methodology, allows for efficient access to a new area of chemical space. Additionally, molecular modeling and in cellulo screening was employed to therapeutically validate the compounds formed with this method.

Entities:  

Keywords:  Heterocycle Formation; MDM2/MDMX; Multicomponent Reaction; Post-Ugi Modifications; Ugi Condensation

Year:  2017        PMID: 30140731      PMCID: PMC6103208          DOI: 10.1002/slct.201702179

Source DB:  PubMed          Journal:  ChemistrySelect        ISSN: 2365-6549            Impact factor:   2.109


  48 in total

Review 1.  "Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'.

Authors:  Christopher Hulme; Vijay Gore
Journal:  Curr Med Chem       Date:  2003-01       Impact factor: 4.530

2.  Solid-phase synthesis of benzofused tricycles based on benzimidazole from resin-bound 3-(2-aminophenylamino)-2-seleno-ester.

Authors:  Xian Huang; Jian Cao; Jianqiang Huang
Journal:  J Comb Chem       Date:  2009 Jul-Aug

3.  One-pot synthesis of 4,5-biphenyl-2-pyrimidinylguanidine derivatives.

Authors:  Zun-Ting Zhang; Fei-Fei Xu; Mi-Xiang Gao; Li Qiu
Journal:  J Comb Chem       Date:  2009 Sep-Oct

4.  General one-pot, two-step protocol accessing a range of novel polycyclic heterocycles with high skeletal diversity.

Authors:  Zhigang Xu; Muhammad Ayaz; Alexandra A Cappelli; Christopher Hulme
Journal:  ACS Comb Sci       Date:  2012-07-12       Impact factor: 3.784

5.  Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology.

Authors:  Brendan Frett; Francesca Carlomagno; Maria Luisa Moccia; Annalisa Brescia; Giorgia Federico; Valentina De Falco; Brittany Admire; Zhongzhu Chen; Wenqing Qi; Massimo Santoro; Hong-yu Li
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-30       Impact factor: 15.336

6.  Two step syntheses of fused quinoxaline-benzodiazepines and bis-benzodiazepines.

Authors:  Zhigang Xu; Justin Dietrich; Arthur Y Shaw; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2010-08-25       Impact factor: 2.415

Review 7.  Albendazole: a review of anthelmintic efficacy and safety in humans.

Authors:  J Horton
Journal:  Parasitology       Date:  2000       Impact factor: 3.234

8.  Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.

Authors:  Rogier A Smits; Herman D Lim; Agnes Hanzer; Obbe P Zuiderveld; Elena Guaita; Maristella Adami; Gabriella Coruzzi; Rob Leurs; Iwan J P de Esch
Journal:  J Med Chem       Date:  2008-03-22       Impact factor: 7.446

9.  6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.

Authors:  U J Ries; G Mihm; B Narr; K M Hasselbach; H Wittneben; M Entzeroth; J C van Meel; W Wienen; N H Hauel
Journal:  J Med Chem       Date:  1993-12-10       Impact factor: 7.446

10.  Synthesis and antiviral evaluation of benzimidazoles, quinoxalines and indoles from dehydroabietic acid.

Authors:  Tatiana Fonseca; Bárbara Gigante; M Matilde Marques; Thomas L Gilchrist; Erik De Clercq
Journal:  Bioorg Med Chem       Date:  2004-01-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.